Steve Damment
Gründer bei Aluztura Bio Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Stephen Stamp | M | 62 | 5 Jahre | |
| James Ford | M | - | 29 Jahre | |
| David Redfern | M | 57 | 30 Jahre | |
| Dmitry Zamoryakhin | M | 44 | 3 Jahre | |
| Graham Rivers | M | - | 26 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Craig Cook | M | 57 | - | |
| Nicholas Robbins-Cherry | M | 54 | - | |
| James Phillips | M | 61 | 5 Jahre | |
| Richard Sykes | M | 79 | 7 Jahre | |
| William Louv | M | - | 21 Jahre | |
| Jeff Jonas | M | 71 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 Jahre |
| Pavlo Protopapa | M | 57 | - | |
| John Johnston | M | 65 | 5 Jahre | |
| Christopher Viehbacher | M | 64 | 20 Jahre | |
| Julian Heslop | M | 70 | 13 Jahre | |
| Tatjana Anni Hilde May | F | 58 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 7 Jahre |
| Alex Howarth | M | 55 | 10 Jahre | |
| Michèle Barzach | M | - | 7 Jahre | |
| Michele Luzi | M | 66 | 9 Jahre | |
| Robert Carr | M | - | 26 Jahre | |
| Kimberly Park | F | 60 | 12 Jahre | |
| Sam Barker | M | - | 1 Jahre | |
| Thierry Loriot | M | - | - | |
| Ian Pitfield | M | 58 | 23 Jahre | |
| Hu Li | M | 59 | 19 Jahre | |
| Roger Connor | M | - | 24 Jahre | |
| Sjoerd Wadman | M | - | 12 Jahre | |
| Robin M. Young | M | 57 | 7 Jahre | |
| Monica Viziano | M | 57 | 6 Jahre | |
| Christopher Tovey | M | 59 | 19 Jahre | |
| Lawson Macartney | M | 66 | 12 Jahre | |
| Anne Brindley | M | 59 | 3 Jahre | |
| David M. Pernock | M | 69 | 16 Jahre | |
| Song Gao | M | 52 | 22 Jahre | |
| Peter John Murray | M | - | - | |
| Carol Ashe | F | 66 | 13 Jahre | |
| Jay C. Strum | M | - | 14 Jahre | |
| John Lepore | M | - | 15 Jahre | |
| Daniel G. Marquess | M | 55 | 4 Jahre | |
| Nick Hirons | M | - | - | |
| Deborah Waterhouse | F | 57 | - | |
| Mark A. Smith | M | 68 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 1 Jahre |
| Vivid Sehgal | M | 56 | 6 Jahre | |
| Brian Blakey | M | 61 | 6 Jahre | |
| Edgar Cale | M | 60 | 21 Jahre | |
| Myra Rosario Herrle | M | - | 9 Jahre | |
| Dean Hakanson | M | 72 | 7 Jahre | |
| David Rowe | M | 57 | 20 Jahre | |
| Gregg Brandyberry | M | - | 16 Jahre | |
| Melissa Beelen | F | - | 12 Jahre | |
| Duncan Learmouth | M | - | - | |
| Lisa Bright | F | 56 | 17 Jahre | |
| Michael Allen Luther | M | 67 | 15 Jahre | |
| Clare Khan | M | 72 | 11 Jahre | |
| James Wu | M | - | 10 Jahre | |
| Lisa Trivison Beck | F | 62 | 24 Jahre | |
| Charlie Sanders | M | 91 | 5 Jahre | |
| Paul Carter | M | 63 | 10 Jahre | |
| Neil Pegg | M | - | - | |
| Randall K. Johnson | M | 77 | 20 Jahre | |
| Tamar Howson | F | 75 | 9 Jahre | |
| James Andrews Grant | M | 86 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 6 Jahre |
| Howard H. Pien | M | 66 | 12 Jahre | |
| George Poste | M | 79 | 7 Jahre | |
| Eric Carter | M | 72 | - | |
| Joseph M. Spagnardi | M | 60 | 11 Jahre | |
| Faheem Hasnain | M | 65 | 14 Jahre | |
| Leslie Hudson | M | 76 | 6 Jahre | |
| David John Kappler | M | 76 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 Jahre |
| Matthew Emmens | M | 72 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 Jahre |
| Maxine Gowen | M | 66 | 10 Jahre | |
| Robert Ruffolo | M | 74 | 16 Jahre | |
| Anita Graham | F | 52 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 Jahre |
| Tim Tyson | M | 71 | 6 Jahre | |
| Dean Mitchell | M | 68 | 15 Jahre | |
| Roger L. Hawley | M | 71 | 14 Jahre | |
| Joseph Schachle | M | 59 | 3 Jahre | |
| Patrick J. Langlois | M | 78 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 3 Jahre |
| Paul Magrez | M | - | 4 Jahre | |
| David Laskow-Pooley | M | 69 | 8 Jahre | |
| Adrian Rawcliffe | M | 52 | 17 Jahre | |
| Lieven Nuyttens | M | 57 | 6 Jahre | |
| Robert G. Pietrusko | M | 76 | 1 Jahre | |
| Marc Rubin | M | 69 | 13 Jahre | |
| Christopher J. Morl | M | 65 | 3 Jahre | |
| Dimitri Dimitriou | M | - | 5 Jahre | |
| Douglas B. Snyder | M | 60 | 6 Jahre | |
| Kathleen Anne Nealon | F | 70 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 Jahre |
| David Lawrence | M | 61 | 13 Jahre | |
| Lisa Porter | M | 60 | 5 Jahre | |
| Argeris Karabelas | M | 71 | 6 Jahre | |
| Barbara H. Deptula | F | 69 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 Jahre |
| Gregory D. Flexter | M | 68 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 Jahre |
| Eliseo Salinas | M | 69 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 Jahre |
| Michael V. Milburn | M | - | 10 Jahre | |
| Elaine Jones | M | 69 | - | |
| Huai Zheng Peng | M | 62 | 1 Jahre | |
| Leon Palandjian | M | 54 | 3 Jahre | |
| Michael Cola | M | 64 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 Jahre |
| Wissam Al-Adani | M | 50 | 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Steve Damment
- Persönliches Netzwerk
